Dr. Evan Ryan Restelli, DO

Dr. Restelli practices at CarolinaEast Internal Medicine - Pollocksville in Pollocksville, North Carolina.

Dr. Restelli's NPI, 1003923814, was assigned on August 25, 2006. Dr. Restelli graduated from Philadelphia College of Osteopathic Medicine in 1999. Dr. Restelli holds North Carolina license 2015-00180.

Dr. Restelli's primary practice is CarolinaEast Internal Medicine - Pollocksville, at 137 Medical Lane, Pollocksville, NC 28573. The practice phone is (252) 635-3849.

Dr. Restelli's primary practice is CarolinaEast Internal Medicine - Pollocksville in Pollocksville, North Carolina. Dr. Restelli is also affiliated with CarolinaEast Medical Center. The medical group on file is CarolinaEast Heart Center, New Bern. Dmand AI also links Dr. Restelli to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Restelli's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Restelli practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Restelli's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Restelli is licensed in North Carolina.

CMS data shows 48,881 Medicare services from Dr. Restelli across 39 procedure codes in 2024, for 760 Medicare patients. Medicare paid $1,018,534 for them.

CMS counts 760 Medicare patients who saw Dr. Restelli in 2024. The largest group is 75 to 84, with 303 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Restelli's median patient age at 72, with 50% women.

In 2024, Dr. Restelli wrote 3,780 Medicare Part D claims for 493 patients. CMS names the drug for 3,585 of them, across 42 drugs with 11 or more claims each, at $1,201,803 in total drug cost. In 2023, CMS named 2,728 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 73 out of 100 for Dr. Restelli for performance year 2024, reported as part of a group. Dr. Restelli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Restelli as offering telehealth.

CMS Open Payments shows 554 general payments to Dr. Restelli from 31 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. AstraZeneca Pharmaceuticals LP paid the most, $3,215.

Dr. Restelli graduated from Philadelphia College of Osteopathic Medicine in 1999.